15 أبريل #adjuvant #Docetaxel #Early-Stage Breast Cancer #Prospective #Real-Life #Toxicity Toxicities Associated with Docetaxel-Based Regimens in the Adjuvant Treatment of Early-Stage Breast Cancer: A Multicenter Prospective Real-Life Experience by Dr. Fadi Farhat 0
19 مارس #Descriptive Study #gastric cancer #Institutional #Lebanon Characteristics of Gastric Cancer in Lebanon: a Descriptive Study from a Single Institutional Experience by Dr. Fadi Farhat 0
11 فبراير #hematology #Middle East #North Africa #substandard medicines On the use of substandard medicines in hematology: An emerging concern in the Middle East and North Africa region by Dr. Fadi Farhat 0
05 فبراير #case report #PET scan #Rare #Rosai-Dorfman disease (18) F-fluoro-2-deoxyglucose positron emission-computed tomography in a rare cutaneous form of Rosai-Dorfman disease: A case report by Dr. Fadi Farhat 0
28 ديسمبر #Article #Covid19 The Concept of Biosimilars: From Characterization to Evolution—A Narrative Review by Dr. Fadi Farhat 0
07 نوفمبر #biomarkers #immuno-histochemistry #Next-generation #personalized therapy Next-generation sequencing and immuno-histochemistry profiling identify numerous biomarkers for personalized therapy of endometrioid endometrial carcinoma by Dr. Fadi Farhat 0
28 سبتمبر #Adenocarcinoma #case report #Diagnostic #Hepatoid #literature #review #Stomach #Therapeutic Hepatoid Adenocarcinoma of the Stomach: A Challenging Diagnostic and Therapeutic Disease through a Case Report and Review of the Literature by Dr. Fadi Farhat 0
05 يوليو #BRAF #Lymph Node Metastases #Mutations #NRAS #Papillary Thyroid Carcinoma #Primary BRAF and NRAS Mutations in Papillary Thyroid Carcinoma and Concordance in BRAF Mutations Between Primary and Corresponding Lymph Node Metastases by Dr. Fadi Farhat 0
26 أبريل #botryoid rhabdomyosarcoma #case report #Chemotherapy-induced differentiation #literature #review Chemotherapy-induced differentiation to cure botryoid rhabdomyosarcoma: a case report and review of the literature by Dr. Fadi Farhat 0
01 أبريل #Adenocarcinoma #ALK #EGFR #Levant countries #Lung #Mutations #prevalence #Prospective Prevalence of EGFR and ALK Mutations in Lung Adenocarcinomas in the Levant Area – a Prospective Analysis by Dr. Fadi Farhat 0
